1 Min Read
LONDON, July 17 (Reuters) - Elan Corporation PLC : * FDA grant fast track designation to ELND005 for the treatment of
neuropsychiatric symptoms in alzheimer’s disease * Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.